• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化的骨科表现。

Orthopedic Manifestations of Cystic Fibrosis.

出版信息

Orthopedics. 2021 May-Jun;44(3):e440-e445. doi: 10.3928/01477447-20210415-03. Epub 2021 May 1.

DOI:10.3928/01477447-20210415-03
PMID:34039211
Abstract

Cystic fibrosis (CF) is a relatively common disease seen in Whites of northern European descent. Classically, it was a lethal disease and uncommon for the orthopedic practitioner to interact with CF patients. Recent pharmaceutical breakthroughs targeting the CF transmembrane conductance regulator (CFTR) gene have significantly prolonged patient life expectancy. This makes it increasingly likely that orthopedic surgeons will encounter CF patients in their clinic. In this article, the authors discuss pertinent musculoskeletal manifestations of the CF population, including the increased risk of decreased bone mineral density and bone mineral content, muscle deconditioning, spinal kyphosis, fractures, and elevated systemic inflammation predisposing these individuals to CF-related arthralgia. The diagnoses are grouped into subspecialties (arthroplasty, pediatrics, spine, sports, and trauma) most likely to evaluate the patient. Additionally, the authors review treatment options for these conditions and discuss the need for these patients to be seen in the perioperative period by their CF care team for patient optimization due to their diminished pulmonary function. Interspersed with this literature review, the authors present 2 unique cases. The first case details a patient with pain over her spine due to multilevel spinous process bursitis caused by a high-frequency chest wall oscillation system, which masquerades as an infection. The second case is a non-contact midsubstance rectus femoris tear in an athlete. These cases highlight the need for increased vigilance for uncommon diagnoses in the CF patient population. [. 2021;44(3):e440-e445.].

摘要

囊性纤维化(CF)是一种在北欧白种人中较为常见的疾病。传统上,它是一种致命的疾病,骨科医生很少与 CF 患者接触。最近针对 CF 跨膜电导调节因子(CFTR)基因的药物突破显著延长了患者的预期寿命。这使得骨科医生在诊所中遇到 CF 患者的可能性越来越大。本文作者讨论了 CF 人群中相关的肌肉骨骼表现,包括骨密度和骨矿物质含量降低、肌肉功能下降、脊柱后凸、骨折和全身炎症增加,这些都会导致 CF 相关关节痛。这些诊断分为最有可能评估患者的亚专科(关节置换、儿科、脊柱、运动和创伤)。此外,作者还回顾了这些疾病的治疗选择,并讨论了这些患者由于肺功能下降,需要在围手术期由 CF 护理团队进行优化治疗。在文献综述中穿插了 2 个独特的病例。第一个病例详细描述了一名患者因高频胸廓振荡系统导致多个棘突滑囊炎而出现脊柱疼痛,这被误诊为感染。第二个病例是一名运动员发生非接触性股直肌中段撕裂。这些病例强调了在 CF 患者群体中需要更加警惕不常见的诊断。[2021;44(3):e440-e445.]。

相似文献

1
Orthopedic Manifestations of Cystic Fibrosis.囊性纤维化的骨科表现。
Orthopedics. 2021 May-Jun;44(3):e440-e445. doi: 10.3928/01477447-20210415-03. Epub 2021 May 1.
2
Acute Recurrent and Chronic Pancreatitis as Initial Manifestations of Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Disorders.急性复发性和慢性胰腺炎作为囊性纤维化和囊性纤维化跨膜电导调节因子相关疾病的初始表现。
Pancreas. 2019 Aug;48(7):888-893. doi: 10.1097/MPA.0000000000001350.
3
CFTR: cystic fibrosis and beyond.CFTR:囊性纤维化及其他。
Eur Respir J. 2014 Oct;44(4):1042-54. doi: 10.1183/09031936.00228013. Epub 2014 Jun 12.
4
Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.囊性纤维化跨膜传导调节因子突变的临床意义
Clin Chest Med. 1998 Sep;19(3):443-58, v. doi: 10.1016/s0272-5231(05)70092-7.
5
[Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].[意大利囊性纤维化注册机构(ICFR)。2015 - 2016年报告]
Epidemiol Prev. 2019 Jul-Aug;43(4S1):1-36. doi: 10.19191/EP19.4.S1.067.
6
Cystic-fibrosis-like disease unrelated to the cystic fibrosis transmembrane conductance regulator.与囊性纤维化跨膜传导调节因子无关的囊性纤维化样疾病
Hum Genet. 1998 May;102(5):582-6. doi: 10.1007/s004390050744.
7
Cystic fibrosis: experience in one institution.囊性纤维化:一家机构的经验
J Microbiol Immunol Infect. 2014 Aug;47(4):358-61. doi: 10.1016/j.jmii.2012.06.005. Epub 2012 Sep 16.
8
Unique mutations of the cystic fibrosis transmembrane conductance regulator gene of three cases of cystic fibrosis in Nagasaki, Japan.日本长崎三例囊性纤维化患者囊性纤维化跨膜传导调节基因的独特突变
Intern Med. 2009;48(15):1327-31. doi: 10.2169/internalmedicine.48.2078. Epub 2009 Aug 3.
9
Applying Cystic Fibrosis Transmembrane Conductance Regulator Genetics and CFTR2 Data to Facilitate Diagnoses.应用囊性纤维化跨膜传导调节因子遗传学和CFTR2数据辅助诊断。
J Pediatr. 2017 Feb;181S:S27-S32.e1. doi: 10.1016/j.jpeds.2016.09.063.
10
Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.鲁马卡托和依伐卡托用于囊性纤维化患者的治疗:当前证据与未来前景
Ther Adv Respir Dis. 2015 Dec;9(6):313-26. doi: 10.1177/1753465815601934. Epub 2015 Sep 28.

引用本文的文献

1
Musculoskeletal aspects of respiratory function in cystic fibrosis: a cross-sectional comparative study.囊性纤维化患者呼吸功能的肌肉骨骼方面:一项横断面比较研究。
Eur Clin Respir J. 2024 May 8;11(1):2350206. doi: 10.1080/20018525.2024.2350206. eCollection 2024.
2
Treatment of cystic fibrosis related bone disease.囊性纤维化相关骨病的治疗。
J Clin Transl Endocrinol. 2021 Dec 21;27:100291. doi: 10.1016/j.jcte.2021.100291. eCollection 2022 Mar.